p53 and PUMA: A Deadly Duo | Science
Marie Puma - Typed Resume Signed | HistoryForSale Item 310336
PUMA Antibody - Cat. No. 3041 | ProSci
Phosphorylation of Puma modulates its apoptotic function by regulating protein stability | Cell Death & Disease
PUMA, a Novel Proapoptotic Gene, Is Induced by p53 - ScienceDirect
RCSB PDB - 5UUL: Human Bfl-1 in complex with PUMA BH3
Biomolecules | Free Full-Text | The Bcl-2 Family: Ancient Origins, Conserved Structures, and Divergent Mechanisms
A review of the role of Puma, Noxa and Bim in the tumorigenesis, therapy and drug resistance of chronic lymphocytic leukemia | Cancer Gene Therapy
BBC3 Gene - GeneCards | BBC3 Protein | BBC3 Antibody
A review of the role of Puma, Noxa and Bim in the tumorigenesis, therapy and drug resistance of chronic lymphocytic leukemia | Cancer Gene Therapy
Biomolecules | Free Full-Text | Advanced Strategies for Therapeutic Targeting of Wild-Type and Mutant p53 in Cancer
p53- and Drug-Induced Apoptotic Responses Mediated by BH3-Only Proteins Puma and Noxa | Science
PUMAα/β Antibody (G-3) | SCBT - Santa Cruz Biotechnology
BH3-Only Proteins Noxa and Puma in Apoptosis Regulation | Encyclopedia MDPI
P53-independent restoration of p53 pathway in tumors with mutated p53 through ATF4 transcriptional modulation by ERK1/2 and CDK9 | bioRxiv
PUMA Antibody | R30371 NSJ Bioreagents
SciELO - Brasil - Prima-1 induces apoptosis in bladder cancer cell lines by activating p53 Prima-1 induces apoptosis in bladder cancer cell lines by activating p53
Primary information of p53 gene
Spatiotemporal Control of CNS Myelination by Oligodendrocyte Programmed Cell Death through the TFEB-PUMA Axis. - Abstract - Europe PMC
Frontiers | Targeting the Bcl-2 Family in B Cell Lymphoma
PUMA Antibody - Cat. No. 3041 | ProSci
PUMA, a Novel Proapoptotic Gene, Is Induced by p53 - ScienceDirect
Gene-specific repression of the p53 target gene PUMA via intragenic CTCF–Cohesin binding
Cancers | Free Full-Text | p53 Acetylation: Regulation and Consequences
PUMA Antibody - Cat. No. 3041 | ProSci
